Latest Stories
As we come within a stone’s throw of Nov. 5, we can’t help but wonder if and how the election outcome will impact health care policy, and cancer policy in particular.
Guest Editorial
As 2024 approaches, it’s anyone’s guess whether an already complex health care ecosystem gets to turn the corner on the mixed legacies of 2023—including record high prices on new blockbuster medications coupled with drug shortages on existing generics, persistent staff shortages and battered hospital margins, and a continued emphasis on value-based care programs by insurers.
